News archive
On this page you can search for older news. Choose a topic, type of news or enter your own keyword to filter out news.
View compact

22 December, 2022
Tissue and Motion conference 2022Following a hiatus of 3 years due to Covid-19, the KI Research Network Tissue and Motion rose to the occasion of hosting the 11th Tissue and Motion conference, which was held at the Djurönäset Hotel on 9th – 10th November 2022.
News

14 October, 2022
They are awarded KAW project grants in 2022Four research projects coordinated from Karolinska Institutet have been awarded project grants by Knut and Alice Wallenberg Foundation (KAW) in 2022. This means that, over SEK 135 million are allocated to KI research in the fields of immunology, neuroscience, and stem cell biology.
News

Heart progenitors spontaneously regenerate cardiac muscle via a tight junction “honeycomb” in salamanders. Whether there are endogenous adult heart progenitors that can replenish damaged muscle cells remained controversial.
News

1 October, 2020
Stem cells can help repair spinal cord after injurySpinal cord injury often leads to permanent functional impairment. In a new study published in the journal Science researchers at Karolinska Institutet show that it is possible to stimulate stem cells in the mouse spinal cord to form large amounts of new oligodendrocytes, cells that are essential to the ability of neurons to transmit signals, and thus to help repair the spinal cord after injury.
News

27 January, 2020
‘Body-on-Chip’ technology could accelerate drug testingA multiple organ-on-chip platform developed by researchers at KTH Royal Institute of Technology, Karolinska Institutet and Harvard University could drastically accelerate drug testing. The technology, described today in Nature Biomedical Engineering, provides accurate predictions of drug effects prior to clinical testing.
News

1 October, 2019
New CRISPR-Cas9 variant may boost precision in gene editingResearchers have developed a new variant of the gene editing technique CRISPR-Cas9 that has the potential to increase precision during gene therapy in humans. The new variant reduced unintended changes in DNA compared to its wildtype, suggesting it could play a role in gene therapies that require high precision. The study by researchers from Karolinska Institutet’s Ming Wai Lau Centre of Reparative Medicine in Hong Kong is published in the journal PNAS.
News









News
News